Introduction
The protein hormone insulin plays a decisive role in the control of mammalian glucose homeostasis. In adults, production of insulin is stringently restricted to the B cells of the endocrine pancreas.
The major mechanism directing this specificity operates at the transcriptional level; as a result, insulin mRNA levels are extremely low in n0n-B cells, of the order of 10' lower than in /? cells. Studies from several laboratories indicate that multiple transcriptional controls, both negative and positive, participate in generating this large differential (reviewed in Philippe [ 11) .
Insulin genes have been cloned and characterized from a wide range of species including primates, carnivores, rodents, birds, fish and amphibians [l-31. Most species possess a single insulin gene: mouse, rat, Xenopus and possibly some species of fish possess a second non-allelic gene. it has been suggested that the second gene of rodents was derived from the first by a process of reverse transcription of a rare partially-spliced germline transcript 141. Sequence comparisons among mammalian insulin genes revealed significant conservation in the 5'-flanking regions especially up to about 350 bp from the transcription start site [Z] , raising the possibility that cell-specific transcription patterns are directed by DNA sequences in this region. Indeed, recombinant plasmids containing 400-600 bp of flanking DNA derived from insulin genes of rat were able to direct expression of a linked reporter gene to / 3 cells in tissue culture and transgenic mice [5, 61 . Subsequently several groups performed detailed mutagenesis studies on the flanking regions of rat and human genes . The picture which emerges is one of significant complexity: in common with findings with other protein coding genes [12] , it appears that multiple &-elements contribute to the overall pattern of expression. Most of the characterized insulin elements appear to function posiAbbreviations used: IEB 1,2, insulin enhancer box 1,2; IEF 1.2, insulin enhancer factor; EMSA, electrophoretic mobility shift assay; BCFlLEFl, B cell factor 11 lymphoid enhancer factor 1; bHLH, basic-helix-loophelix; IESF1, insulin enhancer specific factor 1.
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tively, that is they serve as binding sites for positive transcription factors in # l cells. However, some apparently function as binding sites for negativelyacting factors (repressors) in non-B cells [9, 10, [13] [14] [15] .
Positive control mechanisms
One of the most highly conserved sequences in the insulin flanking region is the sequence known as the insulin enhancer box 1 (IEB1) [ 161 [also referred to as the NIR box [ 171, or the insulin control element (ICE) [ 1811 -see Figure 1 . Mutational analysis indicates that it functions in vivo as a key element in transcription [7] . In the rat insulin I gene (but not the rat insulin I1 or the human insulin gene) there is a very closely related sequence denoted IER2 [ 161 (FAR box [17] ) -see Figure 1 , which is likewise essential for efficient transcription [7] . Upon dimerization, the IEB sequence is capable of directing expression of a reporter molecule specifically in B cells [16] . The IEB sequences are closely related to the 'E box' transcriptional control elements (con- is absent from all non-endocrine cells tested to date. Although IEFl is absent from lymphocytes, a distinct, lymphoid-specific E box binding activity termed B cell factor 1 (BCF1) [22] or lymphoid enhancer factor 1 (LEF1) [21] has been detected.
This binding activity represents a good candidate for a lymphoid-cell-specific transcription factor since E boxes have been shown to play an important role in directing efficient in vivo transcription of immunoglobulin genes [ 231. -100
-I bp sequences, we and others have used IEB probes to screen expression cDNA libraries derived from / 3 cells. Screening was performed in parallel to identify the factors involved in activation through immunoglobulin E box sequences. The result has been the isolation of a number of cDNA clones which appear to be derived from a single gene, termed the E2A gene "241. This gene generates at least two major protein products as a consequence of alternative splicing. The products are denoted as E47 and E l 2 for human [ZS], A1 and A7 for mouse [26] , Pan-1 and Pan-2 for rat [27] and shPan-1 and shPan-2 for hamster [28] . The E2A gene products are of particular interest since they possess a characteristic DNA binding/dimerization domain known as basic-helix-loop-helix (bHLH) [25] ; structurally related motifs have been identified in a number of other known or putative transcription factors and developmental regulatory proteins [ZS] . In order to determine whether the EZA proteins are related to IEFl and BCFl/LEFl, antibodies were generated to the C-terminal portion of the cloned gene product. These antibodies were incubated with nuclear extracts prior to mixing with target E box DNA. Pre-incubation led to interference with the binding of IEFl [Zl, 29, 301 and BCFl/LEFl [21, 22] , indicating that both IEFl and BCFl/LEFl are immunologically related to the HLH proteins (Figure 3a) . Recognition of BCFl/ LEFl was significantly more efficient as determined by an antibody dilution experiment (Figure 3a) . Recently, two new E2A-related genes have been described their products are similar to those of EZA, particularly in the C-terminal region spanning the HLH domain [31, 321. To characterize the E box binding complexes further, we generated polyclonal antibodies directed against the N-terminal portion of the A1 protein. These antibodies also recognize both IEFl and BCFl/LEFl (Figure 3b  lanes 4, 8) indicating that A1/7, or a very closely related protein, is a component of both complexes. As before, recognition of BCFl/LEFl was more efficient than of IEFl (Figure 3b ). To define the subunit structure of these complexes, we used an in vitro subunit exchange assay [33] . This assay involved mixing of nuclear extracts with in vitro-translated HLH proteins of defined molecular masses. Under the experimental condi- 
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Comparison of E box sequences derived from the rat 
Creatine kinase Chymotrypsin CCAAT CANNTG Consensus tions used, the primary determinant of complex mobility in EMSA is molecular mass. Thus it is possible to use electrophoretic migration to obtain a measure of molecular mass of the protein component of a DNA-protein complex. Standard curves were established using a series of in vitro translated HLH proteins. The analysis indicates that IEF1 is a 
Negative control mechanisms
In addition to the above positive control mechanisms, there appear to be several distinct regulatory mechanisms which function in negative fashion, via sequence elements located in the S'-flanking region [9, 10, [13] [14] [15] . Typically these activities were detected in n0n-B cells and were absent from /3 cells. The protein factors responsible for functioning via these sequences have not yet been defined. As an additional approach to investigating negative control mechanisms, we generated hybrid cells between p cell and fibroblasts; the resulting hybrid cells maintained the insulin genes of both parents, yet expression of the insulin gene was undetectable using Northern blot analysis [34, 351 . Using the very sensitive procedures of the polymerase chain reaction (PCR), we showed that insulin mRNA levels in hybrid cells are at least 105-fold lower than in the parental / 3 cells (D. Leshkowitz and M. D.
Walker, unpublished results). We analysed the hybrid cells for content of insulin gene transcription factors. Although the factors that recognize the P1 and E2 elements [20] (see Figure 1) were reduced in concentration from 8 to 15-fold in hybrid cells, the closest correlation with the observed extinction of the endogenous insulin gene was observed with IEFl (greater than 100-fold reduction). This appears to result from reduction in levels of the specific HLH subunit IESF1. When nucleic acid and antibody probes for IESFl become available it will be possible to define in more detail the mechanisms leading to the IESFl reduction in hybrid cells.
In parallel studies, we investigated the ability of multiple IEB sequences to activate transcription from a heterologous promoter. Although two copies of IEB sequence were able to activate transcription in p cells, plasmids containing four, six or ten copies unexpectedly show sharply reduced activity, despite the continued ability of IE1 to recognize the multimerized sequences [ 361. Multiple copies were able to inhibit the activity of &-linked enhancers uon transfection to / 3 cells but not other cell types [36] . One interpretation of the data is that p cells contain a cell-specific repressor molecule which inhibits transcription as a consequence of its ability to bind multiple E box sequences. This notion is supported by in vivo competition experiments showing that a plasmid containing multiple E box elements produces activation (derepression) of a cotransfected plasmid containing multiple E box sequences linked to a reporter gene. The recently described factors IEF2 and insulin promoter factor 1 (IPF1) [20] are present in t ! ? cells but absent from a cells; these factors together with
as-yet-incompletely-defined repressor molecules are candidates for such a function.
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Introduction
The islets of Langerhans are complex 'miniature organs' possessing four distinct cell types with distinct functions and programmes of gene expression. How do these different cell types arise from a common precursor and how are their different patterns of gene expression maintained? These questions have been addressed chiefly by examining the expression of the most easily-identified cellspecific products, the islet hormones glucagon ( a cell), insulin (P cell), somatostatin (6 cell) and pancreatic polypeptide (PP cell). As further cell-specific genes are identified and their promoters are cloned, further material becomes available for the study of cell-specific regulation. For instance, the investigation of the islet amyloid polypeptide (IAPP) promoAbbreviations used: IAPI', islet arnyloid polypeptide; HLH, helix-loop-helix; IEB 1.2, insulin enhancer binding sites 1 and 2; IEFl, insulin enhancer factor 1; FLAT, FAK-linked AT-rich region; HNF 1 a , hepatocyte nuclear factor 1 a ; IlJF 1, insulin upstream factor 1; II'F 1, insulin promoter factor 1.
ter and the /? cell-specific glucokinase promoter may shed light upon the regulatory mechanisms shared by genes expressed in the same tissue [l].
Eventually it should become possible to address the question of how tissue-specific regulators of gene expression come to be expressed in restricted subsets of islet cells.
There is some evidence that the four islet cell types arise from a pluripotent precursor, coexpressing islet hormone genes which in the adult are expressed in distinct classes of cells [Z] . 
